Hospital Universitario Virgen Macarena -ko ikertzaileekin lankidetzan egindako argitalpenak (23)

2023

  1. A One Health approach revealed the long-term role of Mycobacterium caprae as the hidden cause of human tuberculosis in a region of Spain, 2003 to 2022

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 12

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. Impact of the “Zero Resistance” program on acquisition of multidrug-resistant bacteria in patients admitted to Intensive Care Units in Spain. A prospective, intervention, multimodal, multicenter study

    Medicina Intensiva, Vol. 47, Núm. 4, pp. 193-202

  4. Polarimetric imaging for the detection of synthetic models of SARS-CoV-2: A proof of concept

    Journal of Quantitative Spectroscopy and Radiative Transfer, Vol. 302

2022

  1. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

    Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 809-815

  2. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  4. Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013

    Journal of Thrombosis and Haemostasis, Vol. 20, Núm. 6, pp. 1390-1399

2021

  1. Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 438-448

2019

  1. Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain

    AIDS, Vol. 33, Núm. 14, pp. 2167-2172

2017

  1. Myths and evidence on the use of botulinum toxin: Spasticity in adults and in children with cerebral palsy

    Revista de Neurologia, Vol. 64, Núm. 10, pp. 459-470

2016

  1. Cognitive, Emotional, Temperament, and Personality Trait Correlates of Suicidal Behavior

    Current Psychiatry Reports, Vol. 18, Núm. 11

2013

  1. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-for the treatment of chronic hepatitis C in HIV-infected patients: The PERICO trial

    Journal of Infectious Diseases, Vol. 206, Núm. 6, pp. 961-968

2008

  1. Antiretroviral-associated portal hypertension: A new clinical condition? Prevalence, predictors and outcome

    Antiviral Therapy, Vol. 13, Núm. 1, pp. 103-107

  2. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients

    Journal of Hepatology, Vol. 49, Núm. 6, pp. 916-922

  3. Efficacy of pegylated interferon plus ribavirin treatment in HIV/ hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1365-1373

  4. Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy

    AIDS Research and Human Retroviruses, Vol. 24, Núm. 7, pp. 935-940

  5. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era

    AIDS Research and Human Retroviruses, Vol. 24, Núm. 5, pp. 679-683

2006

  1. Severe liver disease associated with prolonged exposure to antiretroviral drugs

    Journal of Acquired Immune Deficiency Syndromes, Vol. 42, Núm. 2, pp. 177-182